203 related articles for article (PubMed ID: 23911299)
21. Activation of surfactant protein-B transcription: signaling through the SP-A receptor utilizing the PI3 kinase pathway.
Strayer DS; Korutla L
J Cell Physiol; 2000 Aug; 184(2):229-38. PubMed ID: 10867648
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung.
Tong Q; Zheng L; Dodd-o J; Langer J; Wang D; Li D
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):28-38. PubMed ID: 16166744
[TBL] [Abstract][Full Text] [Related]
23. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.
Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W
Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459
[TBL] [Abstract][Full Text] [Related]
24. Angiomotin-like 2 interacts with and negatively regulates AKT.
Han H; Yang B; Wang W
Oncogene; 2017 Aug; 36(32):4662-4669. PubMed ID: 28368415
[TBL] [Abstract][Full Text] [Related]
25. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression.
Das A; Boggaram V
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L74-84. PubMed ID: 16905641
[TBL] [Abstract][Full Text] [Related]
26. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.
Kim M; Kim M; Park SJ; Lee C; Lim DS
EMBO Rep; 2016 Jan; 17(1):64-78. PubMed ID: 26598551
[TBL] [Abstract][Full Text] [Related]
27. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
28. Biophysical studies and modelling indicate the binding preference of TAZ WW domain for LATS1 PPxY motif.
Verma A; Lin F; Tan YC; Hidayat MN; Jobichen C; Fan H; Sivaraman J
Biochem Biophys Res Commun; 2018 Jul; 502(3):307-312. PubMed ID: 29787761
[TBL] [Abstract][Full Text] [Related]
29. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
30. Erm/thyroid transcription factor 1 interactions modulate surfactant protein C transcription.
Lin S; Perl AK; Shannon JM
J Biol Chem; 2006 Jun; 281(24):16716-26. PubMed ID: 16613858
[TBL] [Abstract][Full Text] [Related]
31. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
Liu CY; Lv X; Li T; Xu Y; Zhou X; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2011 Feb; 286(7):5558-66. PubMed ID: 21189257
[TBL] [Abstract][Full Text] [Related]
32. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
33. The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.
Habbig S; Bartram MP; Sägmüller JG; Griessmann A; Franke M; Müller RU; Schwarz R; Hoehne M; Bergmann C; Tessmer C; Reinhardt HC; Burst V; Benzing T; Schermer B
Hum Mol Genet; 2012 Dec; 21(26):5528-38. PubMed ID: 23026745
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice.
Mitani A; Nagase T; Fukuchi K; Aburatani H; Makita R; Kurihara H
Am J Respir Crit Care Med; 2009 Aug; 180(4):326-38. PubMed ID: 19498055
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta(1) regulation of surfactant protein B gene expression is mediated by protein kinase-dependent intracellular translocation of thyroid transcription factor-1 and hepatocyte nuclear factor 3.
Kumar AS; Gonzales LW; Ballard PL
Biochim Biophys Acta; 2000 Jun; 1492(1):45-55. PubMed ID: 11004479
[TBL] [Abstract][Full Text] [Related]
36. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
[TBL] [Abstract][Full Text] [Related]
37. Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP /TAZ.
Kofler M; Kapus A
Methods Mol Biol; 2021; 2299():197-216. PubMed ID: 34028745
[TBL] [Abstract][Full Text] [Related]
38. TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.
Janse van Rensburg HJ; Lai D; Azad T; Hao Y; Yang X
Cell Signal; 2018 Dec; 52():12-22. PubMed ID: 30138697
[TBL] [Abstract][Full Text] [Related]
39. AMOTL2 inhibits JUN Thr239 dephosphorylation by binding PPP2R2A to suppress the proliferation in non-small cell lung cancer cells.
Cui R; Jiang N; Zhang M; Du S; Ou H; Ge R; Ma D; Zhang J
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118858. PubMed ID: 32950569
[TBL] [Abstract][Full Text] [Related]
40. Simulated microgravity inhibits osteogenic differentiation of mesenchymal stem cells via depolymerizing F-actin to impede TAZ nuclear translocation.
Chen Z; Luo Q; Lin C; Kuang D; Song G
Sci Rep; 2016 Jul; 6():30322. PubMed ID: 27444891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
